Related Experiment Video
Updated: Aug 6, 2026

07:13
ATAC-Seq Optimization for Cancer Epigenetics Research
Published on: June 30, 2022
Accurate, sensitive, and efficient chromatin accessibility quantification at target loci using UNIChro-seq
Michihiro Kono1,2, Hiroaki Hatano1,2, Kenichiro Asahara2
1Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
Nature Communications
|July 20, 2026
Summary
Researchers developed UNIChro-seq, a novel method for analyzing disease-associated genetic variants. This technique precisely quantifies chromatin accessibility, improving functional investigation of autoimmunity risk alleles.
Area of Science:
- Genomics
- Molecular Biology
- Immunology
Background:
- Fine-mapping studies identify numerous disease risk variants, necessitating efficient functional validation.
- Current genetic analysis tools lack the precision for detailed target-loci investigation.
Purpose of the Study:
- To introduce UNIChro-seq, a digital counting method for accessible chromatin molecules at specific genetic loci.
- To enable accurate, sensitive, and efficient quantification of allelic effects for functional genomics.
Main Methods:
- Development and application of UNIChro-seq for digital chromatin molecule counting.
- Investigation of 57 autoimmunity risk alleles and 20 genome-edited variants.
- Utilizing bi-directional genome editing to distinguish true causal effects from false positives.
Main Results:
- UNIChro-seq provides accurate and sensitive allelic effect quantification compared to conventional methods.
- Functional dissection of a LEF1 locus variant reveals its role in T cell dysregulation in rheumatoid arthritis.
- Identified a fraction of edited alleles showing false positive chromatin accessibility effects, distinguishable by bi-directional editing.
Conclusions:
- UNIChro-seq combined with genome editing offers a precise and scalable approach for functional analysis of disease-associated loci.
- This methodology advances the understanding of genetic variants in autoimmune diseases like rheumatoid arthritis.

